Patents by Inventor PAUL FORSYTHE

PAUL FORSYTHE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11135233
    Abstract: A method for preventing or mitigating an acute allergic response in a subject is disclosed. The method includes a step of administering a nutritional composition to the subject. The nutritional composition includes at least one of an acidic or a neutral HMO, but does not include an N-acetyl-lactosamine.
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: October 5, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Steven Davis, Paul Forsythe
  • Publication number: 20200206251
    Abstract: A method for preventing or mitigating an acute allergic response in a subject is disclosed. The method includes a step of administering a nutritional composition to the subject. The nutritional composition includes at least one of an acidic or a neutral HMO, but does not include an N-acetyl-lactosamine.
    Type: Application
    Filed: December 30, 2019
    Publication date: July 2, 2020
    Inventors: RACHAEL BUCK, STEVEN DAVIS, PAUL FORSYTHE
  • Patent number: 10568896
    Abstract: A method for preventing or mitigating an acute allergic response in a subject is disclosed. The method includes a step of administering a nutritional composition to the subject. The nutritional composition includes at least one of an acidic or a neutral HMO, but does not include an N-acetyl-lactosamine.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: February 25, 2020
    Assignee: Abbott Laboratories
    Inventors: Rachael Buck, Steven Davis, Paul Forsythe
  • Publication number: 20190299005
    Abstract: Vagus nerve stimulation effective in treating mood disorders include application of bursts of vagus nerve stimulation pulses having an average inter-burst duration and an average inter-pulse duration within selected intervals. The effectiveness of test agents in treating mood disorders can be determined by monitoring the firing pattern induced by the test agents on the vagus nerve. Test agents capable of inducing a firing pattern of vagus nerve pulses with average inter-burst duration and average inter-pulse duration within the selected intervals are identified as useful in treating a mood disorder.
    Type: Application
    Filed: March 27, 2019
    Publication date: October 3, 2019
    Inventors: John BIENENSTOCK, Paul FORSYTHE, Christine WEST, Wolfgang KUNZE, Karen-Anne NEUFELD
  • Publication number: 20160296544
    Abstract: A method for preventing or mitigating an acute allergic response in a subject is disclosed. The method includes a step of administering a nutritional composition to the subject. The nutritional composition includes at least one of an acidic or a neutral HMO, but does not include an N-acetyl-lactosamine.
    Type: Application
    Filed: November 18, 2014
    Publication date: October 13, 2016
    Applicant: Abbott Laboratories
    Inventors: RACHAEL BUCK, STEVEN DAVIS, PAUL FORSYTHE